Acipimox sodium

Product Specifications

CAS Number

76958-97-9

Target

Others|||Carbonic Anhydrase

Related Pathways

Others|||Metabolism

Bioactivity

Acipimox (K-9321) sodium, a nicotinic acid analogue, functions as an antilipolytic agent by stimulating leptin release, inhibiting lipolysis, and reducing systemic free fatty acids (FFAs) levels, thereby enhancing insulin sensitivity.

Smiles

CC1=[N+]([O-])C=C(C(=O)[O-])N=C1.[Na+]

Molecular Formula

C6H5N2NaO3

Molecular Weight

176.11

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GTR15314404 1 Vial

Lentiviral human UPK3BL1 shRNA (UAS) - Lentiviral human UPK3BL1 shRNA (UAS, RFP) plasmid

Ask

View Details

RC204528L1V 200 µL

RNF113A (NM_006978) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

A129146 100 µL

Anti-CXADR (SAA0357) (Mouse, Monoclonal, IgG2a, kappa)

Ask

View Details

AM20257FC-N 200 µg

Human IgG4 (pFC specific) Mouse Monoclonal Antibody [Clone ID: NI 315 (HP 6206)]

Ask

View Details

MBS136696-01 0.02 mg

Human ABHD17C Protein Lysate

Ask

View Details

MBS136696-02 5x 0.02 mg

Human ABHD17C Protein Lysate

Ask

View Details